Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.02 | 2 |
NAV | ₹406.99 | ₹10.67 |
Fund Started | 01 Aug 2005 | 07 Oct 2024 |
Fund Size | ₹2904.35 Cr | ₹2211.33 Cr |
Exit Load | Exit load of 1% if redeemed less than 1 year | 0.5% for redemption within 90 Days |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 3.70% | 7.09% |
3 Year | 13.82% | - |
5 Year | 15.00% | - |
1 Year
3 Year
5 Year
Equity | 96.00% | 99.26% |
Cash | 3.60% | 0.74% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Maruti Suzuki India Ltd. | 10.00% |
Procter & Gamble Health Ltd. | 5.31% |
Nestle India Ltd. | 5.19% |
Hindustan Unilever Ltd. | 4.38% |
Vedanta Ltd. | 4.21% |
United Spirits Ltd. | 3.64% |
Britannia Industries Ltd. | 3.30% |
Gland Pharma Ltd. | 2.96% |
Infosys Ltd. | 2.87% |
3M India Ltd. | 2.78% |
Name | Assets |
|---|---|
Maruti Suzuki India Ltd. | 9.81% |
Britannia Industries Ltd. | 7.13% |
Hindustan Unilever Ltd. | 6.13% |
Nestle India Ltd. | 3.85% |
Vedanta Ltd. | 3.35% |
Acutaas Chemicals Ltd. | 3.12% |
GE Vernova T&D India Ltd | 2.92% |
United Spirits Ltd. | 2.85% |
Oracle Financial Services Software Ltd. | 2.75% |
JB Chemicals & Pharmaceuticals Ltd. | 2.74% |
Name | Karthikraj Lakshmanan | Harsha Upadhyaya |
Start Date | 29 Apr 2025 | 03 Apr 2025 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of multinational companies. | The scheme is to generate long-term capital appreciation from a portfolio that is invested predominantly in equity and equity related securities of multi-national companies (MNC). |
Launch Date | 01 Aug 2005 | 07 Oct 2024 |
Description
Launch Date